Registration for the 2027 Product First Look Event is now closed.
If you missed the deadline and would like to see if there is still availability, please email, and indicate which session you would like to attend. Note: In person event capacity this year was limited to 200. If you were unable to register for our live event, but still want to learn more about our Medicare Advantage portfolio changes ahead of AEP, we’ll be hosting virtual overviews this September. Stay tuned for registration details.
Rochester: ExcellusBSD@excellus.com
Central NY, Southern Tier & Utica: ExcellusBSD2@excellus.com
Rochester
Tuesday, August 25
Casa Larga Winery
2287 Turk Hill Rd.
Fairport, NY 14450
Morning Session
Registration: 10:00am
Presentation: 10:30am – 12:00pm
Please join us for lunch from
12:00pm – 1:00pm.
Central New York
(includes Southern Tier and Utica)
Wednesday, August 26
Rosamond Gifford Zoo
1 Conservation Pl,
Syracuse, NY 13204
Morning Session
Registration: 10:00am
Presentation: 10:30am – 12:00pm
Please join us for lunch from
12:00pm – 1:00pm.
Excellus BlueCross BlueShield invites you to our 2027 Product First Look Event. This exclusive event gives our brokers an in-depth look at our 2027 Medicare plans and benefit updates.
Join us for presentations on:
Registration closed on Wednesday, August 5. If you have missed the deadline, please contact your Excellus BCBS Account Representative.
Excellus BlueCross BlueShield invites you to our 2024 Product First Look Event. This exclusive event gives our brokers an in-depth look at our 2024 Medicare plans and benefit updates.
Join us for a morning or afternoon session to learn about our:
You must register by Monday, August 7 to ensure a spot at this year's event. If you have missed the deadline, please contact your Excellus BCBS Account Representative.
*Denotes required field
Copyright © {{CurrentYear}} Excellus BlueCross BlueShield, a nonprofit independent licensee of the Blue Cross Blue Shield Association. All rights reserved.
Terms of Use | Web Privacy Policy | Accessibility Statement